Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2007-02-06
2007-02-06
Canella, Karen A. (Department: 1643)
Chemistry: molecular biology and microbiology
Vector, per se
C435S325000, C435S252300, C435S254110, C536S023500
Reexamination Certificate
active
10283722
ABSTRACT:
A novel gene (designated 103P2D6) and its encoded protein are described. 103P2D6 is not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in prostate cancer. 103P2D6 is also expressed in some fetal tissues, and in breast, bladder, lung, bone, colon, pancreatic, testicular, cervical and ovarian cancers. Consequently, 103P2D6 provides a diagnostic and/or therapeutic target for cancers, and the 103P2D6 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
REFERENCES:
patent: 1033401 (2000-09-01), None
patent: 1074617 (2001-02-01), None
patent: WO-98/45435 (1998-10-01), None
patent: WO200055629 (2000-09-01), None
patent: WO200118022 (2001-03-01), None
patent: WO200160860 (2001-08-01), None
patent: WO200162925 (2001-08-01), None
patent: WO200177137 (2001-10-01), None
patent: WO200177291 (2001-10-01), None
patent: WO200194629 (2001-12-01), None
patent: WO200283899 (2002-10-01), None
patent: WO2003025148 (2003-04-01), None
Verma et al (Nature, 1997, vol. 389, pp. 239-242).
Eck et al (Gene-Based Therapy, In: The Pharmacological Basis of Therapeutics, Goodman and Gilman, Ed.s, 1996, pp. 77-101).
Orkin et al (“Report and Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy”, NIH, 1995).
Power et al., Science (1986) 231:1567-1572.
Chester and Hawkins, Tibtech (1995) 13:294-300.
Database EMBL ID: HS444155; Accession number: H08444, XP 002184240 (abstract).
Database EMBL ID: HS069156; Accession number: H03069, XP 002184241 (abstract).
Database EMBL ID: AI928402; Accession number: AI928402, XP 002184242 (abstract).
Database EMBL; Accession number: AC021941, XP 002184509.
Geluk et al., Journal of Immunology (1994) 152:5742-5748 (XP 002184475).
Klein et al., Nat. Med. (1997) 3:402.
Hubert et al., Proc. Natl. Acad. Sci. USA (1999) 96(25):14523-14528.
Pinto et al., Clin. Cancer Res. (1996) 2(9):1445-1451.
Reiter et al., Proc. Natl. Acad. Sci. USA (1998) 95:1735.
Su et al., Proc. Natl. Acad. Sci. USA (1996) 93:7252.
Waldmann et al., Science (1991) 252:1657-1662.
Afar Daniel E. H.
Challita-Eid Pia M.
Faris Mary
Hubert Rene S.
Jakobovits Aya
Agensys, Inc.
Canella Karen A.
Morrison & Foerster / LLP
LandOfFree
103P2D6: tissue specific protein highly expressed in various... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 103P2D6: tissue specific protein highly expressed in various..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 103P2D6: tissue specific protein highly expressed in various... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3825069